Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsIntellectual Property business development Sustainability BIO Health Care Benefits of biotech crops BIO Investor Forum health biotechnology Biotechnology Industry patent Plant biotechnology BIO EVENT BIOTECH biotech industry Food agriculture Animal biotechnology global food crisis FDA
- Most Popular
Latest VideoWhat's Hot & What's Not in Oncology (a web panel co-sponsored by BIO and ShareVault) View All >